| High-Tech Gründerfonds Management GmbH. (2/4/25). "Press Release: Akribion Therapeutics Exits from Stealth with €8m Seed Financing to pioneer RNA-guided, programmable cell depletion". |
2025-02-04 |
| Rentschler Biopharma SE. (1/30/25). "Press Release: Rentschler Biopharma Announces Strategic Realignment of Its Global Business Operations". Laupheim. |
2025-01-30 |
| TME Pharma N.V.. (1/29/25). "Press Release: TME Pharma Announces Collaboration with Aimed Analytics for AI-Driven Drug Discovery and Optimization". Berlin. |
2025-01-29 |
| Yumab GmbH. (1/29/25). "Press Release: Yumab and Inscreenex Get Funding for Innovative Mammalian Display Screening". Braunschweig. |
2025-01-29 |
| Körber Pharma. (1/23/25). "Press Release: Körber – Oliver Weber Appointed as CEO Software in the Business Area Pharma". Lüneburg. |
2025-01-23 |
| Medix Biochemica Oy. (1/22/25). "Press Release: Medix Biochemica Expands Its Offering of Critical IVD Raw Materials to Premium Blockers and Stabilizers by Acquiring Candor Bioscience". Espoo. |
2025-01-22 |
| Arctic Therapeutics. (1/22/25). "Press Release: Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing". Reykjavik & Philadelphia, PA. |
2025-01-22 |
| Pharming Group N.V.. (1/21/25). "Press Release: Pharming to Nominate Biopharmaceutical Leader Fabrice Chouraqui as New Executive Director and Chief Executive Officer". Leiden. |
2025-01-21 |
| Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. |
2025-01-21 |
| Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH". |
2025-01-20 |
| ITM Isotope Technologies Munich SE. (1/16/25). "Press Release: Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO". Chalk River, ON. |
2025-01-16 |
| Rentschler Biopharma SE. (1/16/25). "Press Release: Rentschler Biopharma Provides Update on Personnel Change in Company’s Extended Executive Team". |
2025-01-16 |
| Biosaxony e. V.. (1/16/25). "Press Release: Radiation Made in Saxony – Saxon Radiopharmacy Network nukliD Strengthens International Visibility". |
2025-01-16 |
| Boehringer Ingelheim. (1/16/25). "Press Release: Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia". Ingelheim. |
2025-01-16 |
| SGS S.A.. (1/15/25). "Press Release: Statement. Following Recent Media Commentary SGS Indicates that It Is in Discussions with Bureau Veritas Regarding a Potential Business Combination". |
2025-01-15 |
| Eckert & Ziegler SE. (1/14/25). "Press Release: Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture". Berlin. |
2025-01-14 |
| BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg. |
2025-01-14 |
| European Invesmtent Bank (EIB). (1/14/25). "Press Release: Germany – EIB Provides €35 Million to Formo to Expand Production of Cheese Alternatives Free from Animal Products". |
2025-01-14 |
| ITM Isotope Technologies Munich SE. (1/13/25). "Press Release: ITM and Ariceum Therapeutics Enter into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225". Garching, Munich & Berlin. |
2025-01-13 |
| Daiichi Sankyo Co., Ltd.. (1/13/25). "Press Release: Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH". Tokyo & Basking Ridge, NJ. |
2025-01-13 |
| Forbion Capital Partners. (1/13/25). "Press Release: Forbion Promotes Dirk Kersten to Managing Partner and Strengthens US Team". Naarden. |
2025-01-13 |
| Eckert & Ziegler SE. (1/13/25). "Press Release: Eckert & Ziegler and GlyTherix Extend Collaboration with Actinium-225 Supply Agreement". Berlin & Sydney. |
2025-01-13 |
| GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
| Cube Biotech GmbH. (1/13/25). "Press Release: Cube Biotech, Pioneer in Membrane Protein Production and Purification Technologies, Completes a Transformational Transaction with the Acquisition of IBA Lifesciences". Monheim. |
2025-01-13 |
| RhyGaze AG. (1/10/25). "Press Release: Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration". Basel & Philadelphia, PA. |
2025-01-10 |
| CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA. |
2025-01-10 |
| Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
| Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
| Graph Therapeutics FlexCo. (1/9/25). "Press Release: Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for Immunological Diseases". Vienna. |
2025-01-09 |
| BioLizard N.V.. (1/9/25). "Press Release: BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco". Ghent. |
2025-01-09 |
| Alesta Therapeutics B.V.. (1/8/25). "Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases". Leiden. |
2025-01-08 |
| Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2025-01-07 |
| Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
| Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2025-01-07 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| Innovent Biologics, Inc.. (1/2/25). "Press Release: Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate". San Francisco, CA & Suzhou. |
2025-01-02 |
| Idorsia Ltd.. (12/20/24). "Press Release: Idorsia Provides Update on the Exclusive Negotiations for the Global Rights to Aprocitentan". Allschwil. |
2024-12-20 |
| Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich. |
2024-12-20 |
| Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
| XGen Venture SGR S.p.A.. (12/19/24). "Press Release: XGen Venture Announces Final Closing of €180M ($190M) Life Sciences Fund". Milan. |
2024-12-19 |
| Sanofi S.A.. (12/19/24). "Press Release: Jean-Paul Kress to Join Sanofi’s Board of Directors". Paris. |
2024-12-19 |
| Roche. (12/18/24). "Press Release: Roche Transforms Mass Spectrometry Diagnostics with Launch of cobas Mass Spec Solution". Basel. |
2024-12-18 |
| BioAge Labs, Inc.. (12/18/24). "Press Release: BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions". Richmond, CA. |
2024-12-18 |
| Max Planck Innovation GmbH. (12/17/24). "Press Release: Christoph Hüls Becomes Managing Director of Max Planck Innovation GmbH, Succeeding Jörn Erselius, Who Is Retiring after more than 30 Years of Service". |
2024-12-17 |
| Merck KGaA. (12/17/24). "Press Release: Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio". Darmstadt. |
2024-12-17 |
| Wacker Chemie AG. (12/17/24). "Press Release: Wacker Biosolutions under New Leadership". Munich. |
2024-12-17 |
| Mainz Biomed N.V.. (12/16/24). "Press Release: Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering". Berkeley, CA & Mainz. |
2024-12-16 |
| Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein. |
2024-12-16 |
| Eckert & Ziegler SE. (12/13/24). "Press Release: Eckert & Ziegler Submits GalliaPharm for Approval by Japan’s Health Authority MHLW". Berlin. |
2024-12-13 |
| ITM Isotope Technologies Munich SE. (12/13/24). "Press Release: ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Garching / Munich. |
2024-12-13 |
| Palvella Therapeutics, Inc.. (12/13/24). "Press Release: Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million". Wayne, PA. |
2024-12-13 |
| Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
| Kadans Science Partner. (12/12/24). "Press Release: Kadans Science Partner with the Support of Accumulata to Transform Former Signa Property into Life Science Innovation Hub". Berlin. |
2024-12-12 |
| Evotec SE. (12/11/24). "Press Release: Evotec SE Announces First Projects for LAB eN² Drug Discovery Accelerator with Novo Nordisk". Pratteln. |
2024-12-11 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging". |
2024-12-10 |
| Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg. |
2024-12-10 |
| Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss. |
2024-12-09 |
| Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried. |
2024-12-09 |
| High-Tech Gründerfonds Management GmbH. (12/9/24). "Press Release: HTGF Strengthens Life Science Expertise – Dr. Achim Plum to Become New Managing Director". Bonn. |
2024-12-09 |
| Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen. |
2024-12-06 |
| Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne. |
2024-12-05 |
| Eckert & Ziegler SE. (12/5/24). "Press Release: Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments". Berlin. |
2024-12-05 |
| Leon-Nanodrugs GmbH. (12/5/24). "Press Release: Feasibility Study with Evonik Confirms Leon’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery". Munich, Planegg. |
2024-12-05 |
| ViveBiotech S.L.. (12/4/24). "Press Release: ViveBiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities". |
2024-12-04 |
| Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
| TME Pharma N.V.. (12/4/24). "Press Release: (CORRECTING and REPLACING) TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of T |
2024-12-04 |
| Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
| Eckert & Ziegler SE. (12/3/24). "Press Release: Eckert & Ziegler – Changes in the Executive Board and Supervisory Board". Berlin. |
2024-12-03 |
| Nouscom S.r.l.. (12/3/24). "Press Release: Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer". Basel. |
2024-12-03 |
| Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich. |
2024-12-03 |
| PTC Therapeutics, Inc.. (12/2/24). "Press Release: PTC Therapeutics Enters into a Global License and Collaboration Agreement with Novartis for PTC518 Huntington's Disease Program". Warren, NJ. |
2024-12-02 |
| Eppendorf SE. (12/2/24). "Press Release: Eppendorf SE and DataHow AG Announce Strategic Collaboration to Advance Bioprocess Data Management". Hamburg & Jülich. |
2024-12-02 |
| Evotec SE. (11/29/24). "Press Release: Evotec Announces Change in Management Board. Dr Craig Johnstone Steps Down as Chief Operating Officer Effective 31 December 2024". Hamburg. |
2024-11-29 |
| Mainz Biomed N.V.. (11/29/24). "Press Release: Mainz Biomed Announces Stock Split". Berkeley, CA & Mainz. |
2024-11-29 |
| Idorsia Ltd.. (11/27/24). "Press Release: Idorsia Enters into Exclusive Negotiations for Global Rights to Aprocitentan". Allschwil. |
2024-11-27 |
| Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
| Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel. |
2024-11-26 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Roche. (11/26/24). "Press Release: Roche Enters into a Definitive Agreement to Acquire Poseida Therapeutics, Including Cell Therapy Candidates and Related Platform technologies". Basel. |
2024-11-26 |
| Kyan Health AG. (11/26/24). "Press Release: Kyan Health Raises $16.7m to Upgrade Workplace Wellness with AI-powered Preventative Care". |
2024-11-26 |
| Bico Group AB. (11/25/24). "Press Release: Cellink Announces Further Right-sizing and Launches Sharpened Commercial Agenda". |
2024-11-25 |
| Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
| Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results". Santa Clara, CA. |
2024-11-25 |
| Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Announces New Organizational Structure to Support its Market-Focused Strategy". Santa Clara, CA. |
2024-11-25 |
| Halozyme Therapeutics, Inc.. (11/22/24). "Press Release: Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions". San Diego, CA. |
2024-11-22 |
| Novartis AG. (11/21/24). "Press Release: Addressing Unmet Needs for Inherited Neuromuscular Diseases. Novartis Has Acquired Kate Therapeutics to Further Enhance and Strengthen Our Ongoing Efforts to Advance Gene Therapies for Patients". |
2024-11-21 |
| Versant Ventures. (11/21/24). "Press Release: Versant Ventures Unveils Pep2Tango Therapeutics Inc.". Potomac, MD. |
2024-11-21 |
| Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
| Infrareal Holding GmbH & Co. KG. (11/20/24). "Press Release: Infrareal Takes Over Pharmaceutical and Biotech Site in Orth, Lower Austria". Gütersloh. |
2024-11-20 |
| Halozyme Therapeutics, Inc.. (11/18/24). "Press Release: Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec". San Diego, CA. |
2024-11-18 |
| Halozyme Therapeutics, Inc.. (11/14/24). "Press Release: Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction". San Diego, CA. |
2024-11-14 |
| CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
| Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
| Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid. |
2024-11-13 |
| Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
| Mediaire GmbH. (11/12/24). "Press Release: Mediaire Transforms Radiology with AI, Securing a European €12 Million Investment to Fuel Global Growth". |
2024-11-12 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
